Workflow
Leap Therapeutics(LPTX) - 2019 Q2 - Quarterly Report
LPTXLeap Therapeutics(LPTX)2019-08-09 18:52

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37990 LEAP THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 27-4412575 State or other jurisdiction of (I.R.S. Employer incorporation or organization Identification No.) 47 Thorndike St, Suite B1-1, Cambridge, MA 02141 Address of Principal Executive O ...